ProPhase Labs, Inc. (OTC:PRPH)周五宣布，该公司已与Generating Alpha Ltd.签订股票购买协议，使公司能够在其自行决定的时间内获得高达1000万美元的股权资本。该协议于1月16日签署，赋予ProPhase Labs根据协议中概述的条款，在需要时向投资者出售其普通股的权利，但并非义务。

Garden City, NY, May 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics company, today provided an update regarding its progress ...

Garden City, NY, May 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics company, today provided an update regarding its ...

ProPhase Labs, Inc. PRPH shares rallied 9.1% in the last trading session to close at $14.15. This move can be attributable to notable volume with a higher number of shares being traded than in a ...

Garden City, NY, Feb. 06, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (PRPH) (“ProPhase”), a growth oriented and diversified diagnostics, genomics and biotech company, today provided an update ...

DOYLESTOWN, Pa., Nov. 20, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (the “Company” or “ProPhase”), today ...